Management of Insomnia | New England Journal of Medicine
Jul 17, 2024 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of insomnia symptoms.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH …
Feb 7, 2024 · From the University of Oxford, Oxford (S.A.H.), the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne (Q.M.A.), and the National ...
Hydrocortisone in Severe Community-Acquired Pneumonia | New …
Mar 21, 2023 · New perspectives on community-acquired pneumonia in 388 406 patients: results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009;64:1062-1069. Crossref
The Emerging Threat of H5N1 to Human Health | New England …
Dec 31, 2024 · Against this background, more humans have come into contact with HPAI A(H5N1). Investigators now report in the Journal a series of human cases from the United States and Canada. 2,3 The former ...
Critical Illness in an Adolescent with Influenza A(H5N1) Virus ...
Dec 31, 2024 · On November 4, 2024, a 13-year-old girl with a history of mild asthma and an elevated body-mass index (the weight in kilograms divided by the square of the height in meters) of greater than 35 ...
Dapagliflozin in Patients with Chronic Kidney Disease | New …
Sep 24, 2020 · Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diab...
Pulmonary Arterial Hypertension | New England Journal of Medicine
Dec 15, 2021 · Other new mutations involve ATP13A3 (encoding ATPase 13A3); SOX17, which encodes SRY-box 17 and is a major risk factor for congenital heart disease–associated pulmonary arterial hypertension) 51 ...
Cervical Cancer | New England Journal of Medicine
Jan 1, 2025 · In 2020, an estimated 604,127 new cases of cervical cancer were reported worldwide, ... New England Journal of Medicine. Volume 392 • Number 1 • January 2, 2025. Pages: 56-71. Editor.
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell …
Sep 13, 2024 · Durvalumab is a selective, high-affinity human IgG1 monoclonal antibody that binds to programmed death ligand 1 (PD-L1), blocking its interaction with programmed death 1 (PD-1) and CD80 on ...
Empagliflozin in Patients with Chronic Kidney Disease | New …
Nov 4, 2022 · We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m 2 of body-surface area, or who had ...